Nefazodone Hydrochloride
Spécifications
82752-99-6Numéro CAS
875-483-1Numéro CE
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochlorideNom IUPAC
C25H33Cl2N5O2Formule chimique
506.5 g/molMasse molaire
NEFAZODONE HYDROCHLORIDE; 82752-99-6; Nefazodone Hcl; Dutonin; Serzone; BMY 13754; MJ 13,754-1; DTXSID8046088; MJ-13754-1; BMY-13754; 27X63J94GR; NSC-760344; CHEBI:7495; DTXCID6026088; 2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one hydrochloride; Nefazadone HCl; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one hydrochloride; RefChem:57774; Menfazona; Reseril; Rulivan; 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; 1-(3-(4-(3-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one hydrochloride; MFCD00935760; Nefazodone (hydrochloride); C25H33Cl2N5O2; Nefadar; s5398; 1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta(sup 2)-1,2,4-triazolin-5-one monohydrochloride; 3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl))propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride; 1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-ethyl-4-(2-phenoxyethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one hydrochloride; SMR000449297; CAS-82752-99-6; Nefazodone hydrochloride [USAN]; NCGC00165846-02; UNII-27X63J94GR; SR-01000759312; Serzone (TN); Nefazodone hydrochloride [USAN:USP]; Nefazodonehydrochloride; Nefazodone (hydrochloride)?; SCHEMBL41119; 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one hydrochloride; 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochloride; MLS000758241; MLS000759458; MLS001401457; Nefazodone hydrochloride (USP); orb1223924; orb1304356; CHEMBL1200492; SCHEMBL30054492; HY-B1396R; MSK10523A; GLXC-07455; GLXC-22801; HMS5084E18; HY-B1396; Nefazodone HCl - Bio-X trade mark; Tox21_111735; Tox21_113574; EBC-12785; NEFAZODONE HYDROCHLORIDE [MI]; AKOS015846321; Nefazodone (hydrochloride) (Standard); Tox21_111735_1; AC-1373; CCG-100923; CS-4860; FN26173; KS-1088; NC00173; NSC 760344; BMY-13754-1; NEFAZODONE HYDROCHLORIDE [MART.]; NCGC00165846-04; NEFAZODONE HYDROCHLORIDE [USP-RS]; NEFAZODONE HYDROCHLORIDE [WHO-DD]; 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl- 2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; 3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride; BMY 13754 -1; BN164641; SY059943; N1822; NEFAZODONE HYDROCHLORIDE [ORANGE BOOK]; D00819; NEFAZODONE HYDROCHLORIDE [USP IMPURITY]; NEFAZODONE HYDROCHLORIDE [USP MONOGRAPH]; EN300-6731074; Nefazodone hydrochloride, >=98% (HPLC), solid; F862987; SR-01000759312-6; Q27107509; Nefazodone Hydrochloride 1.0 mg/ml in Methanol (as free base); Nefazodone hydrochloride, United States Pharmacopeia (USP) Reference Standard; 2-(3-(4-(3-CHLOROPHENYL)-1-PIPERAZINYL)PROPYL)-5-ETHYL-2,4-DIHYDRO-4-(2-PHENOXYETHYL)-3H-1,2,4-TRIAZOL-3-ONE MONOHYDROCHLORIDE; 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)-2H-1,2,4-triazol-3(4H)-one hydrochloride; 2-{3-[4-(3-Chloro-phenyl)-piperazin-1-yl]-propyl}-5-ethyl-4-(2-phenoxy-ethyl)-2,4-dihydro-[1,2,4]triazol-3-one hydrochloride; 2-{3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one--hydrogen chloride (1/1)Synonymes
